[{"Assets_0_Q3_USD":7177116000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298095000.0,"NetIncomeLossConverted_3_Q3_USD":1205189000.0,"NetIncomeLossConverted_1_Q3_USD":-258816000.0,"StockholdersEquity_0_Q3_USD":5131192000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30149000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":29831000.0,"EarningsPerShareBasic_1_Q3_USD":-8.68,"EarningsPerShareBasic_3_Q3_USD":40.42,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29815000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29831000.0,"EarningsPerShareDiluted_1_Q3_USD":-8.68,"EarningsPerShareDiluted_3_Q3_USD":39.97,"RevenuesConverted_1_Q3_USD":560633000.0,"RevenuesConverted_3_Q3_USD":1687231000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20191101"}]